Pharmacoinvasive approach for STEMI management is the ideal for Indian scenario

Tenecteplase is better 3rd generation thrombolytic agent because of a single bolus injection hence ease of administration, higher fibrin specificity and no antigenicity
Pause
Love It
Download

Dr.Annapoorna A Kalia

Interventional Cardiologist

Aditya Birla Memorial Hospital, Pune

"Tenecteplase is better 3rd generation thrombolytic agent because of a single bolus injection hence ease of administration, higher fibrin specificity and no antigenicity" Dr.Annapoorna Kalia, Emcure CSI tv


Mail us at editorial@therightdoctors.com. Stay updated on Facebook , Twitter , You Tube and LinkedIn.
Join TheRightDoctors on WhatsApp. Type "JOIN" and send to 9676401536